157 related articles for article (PubMed ID: 15583958)
1. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).
Scherfler C; Sather T; Diguet E; Stefanova N; Puschban Z; Tison F; Poewe W; Wenning GK
J Neural Transm (Vienna); 2005 Aug; 112(8):1025-33. PubMed ID: 15583958
[TBL] [Abstract][Full Text] [Related]
2. Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy).
Mantoan L; Stefanova N; Egger KE; Jellinger KA; Poewe W; Wenning GK
Acta Neuropathol; 2005 Feb; 109(2):191-7. PubMed ID: 15549330
[TBL] [Abstract][Full Text] [Related]
3. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy).
Scherfler C; Puschban Z; Ghorayeb I; Goebel GP; Tison F; Jellinger K; Poewe W; Wenning GK
Neuroscience; 2000; 99(1):43-54. PubMed ID: 10924951
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
5. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
[TBL] [Abstract][Full Text] [Related]
6. In vivo models of multiple system atrophy.
Fernagut PO; Ghorayeb I; Diguet E; Tison F
Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
[TBL] [Abstract][Full Text] [Related]
7. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK
Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
[TBL] [Abstract][Full Text] [Related]
8. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis.
Ghorayeb I; Fernagut PO; Hervier L; Labattu B; Bioulac B; Tison F
Neuroscience; 2002; 115(2):533-46. PubMed ID: 12421620
[TBL] [Abstract][Full Text] [Related]
9. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
Yoon HH; Kim YH; Shin ES; Jeon SR
J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.
Kaindlstorfer C; García J; Winkler C; Wenning GK; Nikkhah G; Döbrössy MD
J Neurosci Res; 2012 Jun; 90(6):1284-95. PubMed ID: 22488729
[TBL] [Abstract][Full Text] [Related]
12. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
Carbone M; Duty S; Rattray M
BMC Neurosci; 2012 Apr; 13():38. PubMed ID: 22480308
[TBL] [Abstract][Full Text] [Related]
13. Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration.
Stefanova N; Mitschnigg M; Ghorayeb I; Diguet E; Geser F; Tison F; Poewe W; Wenning GK
J Neurosci Res; 2004 Oct; 78(1):87-91. PubMed ID: 15372496
[TBL] [Abstract][Full Text] [Related]
14. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
15. Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
Puschban Z; Stefanova N; Petersén A; Winkler C; Brundin P; Poewe W; Wenning GK
Brain Res Bull; 2005 Dec; 68(1-2):54-8. PubMed ID: 16325004
[TBL] [Abstract][Full Text] [Related]
16. Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
Mabandla MV; Nyoka M; Daniels WM
Brain Res; 2015 Oct; 1622():64-71. PubMed ID: 26111646
[TBL] [Abstract][Full Text] [Related]
17. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a multiple system atrophy model in rats using multitracer microPET.
Yoon HH; Lee CS; Hong SH; Min J; Kim YH; Hwang O; Jeon SR
Acta Neurochir (Wien); 2012 May; 154(5):935-40. PubMed ID: 21866326
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
Decressac M; Mattsson B; Björklund A
Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
[TBL] [Abstract][Full Text] [Related]
20. L-dopa response pattern in a rat model of mild striatonigral degeneration.
Kaindlstorfer C; Stefanova N; Garcia J; Krismer F; Döbrössy M; Göbel G; Jellinger K; Granata R; Wenning GK
PLoS One; 2019; 14(6):e0218130. PubMed ID: 31181111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
